Sino BiologicalInc.
Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discover… Read more
Market Cap & Net Worth: Sino BiologicalInc. (301047)
Sino BiologicalInc. (SHE:301047) has a market capitalization of $1.18 Billion (CN¥8.69 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #11374 globally and #2658 in its home market, demonstrating a 0.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sino BiologicalInc.'s stock price CN¥71.44 by its total outstanding shares 121636742 (121.64 Million).
Sino BiologicalInc. Market Cap History: 2021 to 2026
Sino BiologicalInc.'s market capitalization history from 2021 to 2026. Data shows change from $2.73 Billion to $1.18 Billion (-22.84% CAGR).
Sino BiologicalInc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sino BiologicalInc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.67x
Sino BiologicalInc.'s market cap is 1.67 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.41x
Sino BiologicalInc.'s market cap is 8.41 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $2.73 Billion | $965.27 Million | $720.01 Million | 2.82x | 3.79x |
| 2022 | $1.58 Billion | $574.60 Million | $302.96 Million | 2.74x | 5.20x |
| 2023 | $1.33 Billion | $646.39 Million | $260.13 Million | 2.06x | 5.11x |
| 2024 | $1.03 Billion | $613.67 Million | $121.93 Million | 1.67x | 8.41x |
Competitor Companies of 301047 by Market Capitalization
Companies near Sino BiologicalInc. in the global market cap rankings as of March 19, 2026.
Key companies related to Sino BiologicalInc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Sino BiologicalInc. Historical Marketcap From 2021 to 2026
Between 2021 and today, Sino BiologicalInc.'s market cap moved from $2.73 Billion to $ 1.18 Billion, with a yearly change of -22.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.18 Billion | +5.68% |
| 2025 | CN¥1.12 Billion | +9.30% |
| 2024 | CN¥1.03 Billion | -22.91% |
| 2023 | CN¥1.33 Billion | -15.58% |
| 2022 | CN¥1.58 Billion | -42.21% |
| 2021 | CN¥2.73 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sino BiologicalInc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.18 Billion USD |
| MoneyControl | $1.18 Billion USD |
| MarketWatch | $1.18 Billion USD |
| marketcap.company | $1.18 Billion USD |
| Reuters | $1.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.